ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

Janey S.A. Pratt, Allen Browne, Nancy T. Browne, Matias Bruzoni, Megan Cohen, Ashish Desai, Thomas Inge, Bradley C. Linden, Samer Mattar, Marc Michalsky, David Podkameni, Kirk W. Reichard, Fatima Cody Stanford, Meg H. Zeller, Jeffrey Zitsman

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009–2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

Original languageEnglish (US)
Pages (from-to)882-901
Number of pages20
JournalSurgery for Obesity and Related Diseases
Volume14
Issue number7
DOIs
StatePublished - Jul 1 2018
Externally publishedYes

Fingerprint

Bariatric Surgery
Guidelines
Pediatrics
Obesity
Morbid Obesity
Morbidity
Growth Charts
Pediatric Obesity
Bone Development
Obstructive Sleep Apnea
Centers for Disease Control and Prevention (U.S.)
Mental Disorders
Type 2 Diabetes Mellitus
Life Style
Quality of Life

Keywords

  • Adolescent
  • Adolescent obesity
  • Bariatric surgery
  • Childhood obesity
  • Guidelines
  • Guidelines for adolescent bariatric surgery
  • Metabolic and bariatric surgery
  • Morbid obesity
  • Pediatric
  • Type 2 diabetes
  • Weight loss surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Pratt, J. S. A., Browne, A., Browne, N. T., Bruzoni, M., Cohen, M., Desai, A., ... Zitsman, J. (2018). ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surgery for Obesity and Related Diseases, 14(7), 882-901. https://doi.org/10.1016/j.soard.2018.03.019

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. / Pratt, Janey S.A.; Browne, Allen; Browne, Nancy T.; Bruzoni, Matias; Cohen, Megan; Desai, Ashish; Inge, Thomas; Linden, Bradley C.; Mattar, Samer; Michalsky, Marc; Podkameni, David; Reichard, Kirk W.; Stanford, Fatima Cody; Zeller, Meg H.; Zitsman, Jeffrey.

In: Surgery for Obesity and Related Diseases, Vol. 14, No. 7, 01.07.2018, p. 882-901.

Research output: Contribution to journalReview article

Pratt, JSA, Browne, A, Browne, NT, Bruzoni, M, Cohen, M, Desai, A, Inge, T, Linden, BC, Mattar, S, Michalsky, M, Podkameni, D, Reichard, KW, Stanford, FC, Zeller, MH & Zitsman, J 2018, 'ASMBS pediatric metabolic and bariatric surgery guidelines, 2018', Surgery for Obesity and Related Diseases, vol. 14, no. 7, pp. 882-901. https://doi.org/10.1016/j.soard.2018.03.019
Pratt, Janey S.A. ; Browne, Allen ; Browne, Nancy T. ; Bruzoni, Matias ; Cohen, Megan ; Desai, Ashish ; Inge, Thomas ; Linden, Bradley C. ; Mattar, Samer ; Michalsky, Marc ; Podkameni, David ; Reichard, Kirk W. ; Stanford, Fatima Cody ; Zeller, Meg H. ; Zitsman, Jeffrey. / ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. In: Surgery for Obesity and Related Diseases. 2018 ; Vol. 14, No. 7. pp. 882-901.
@article{f36e71e11dc0492bb5e9962e2c13be4d,
title = "ASMBS pediatric metabolic and bariatric surgery guidelines, 2018",
abstract = "The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009–2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120{\%} of the 95th percentile and class III obesity as 140{\%} of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.",
keywords = "Adolescent, Adolescent obesity, Bariatric surgery, Childhood obesity, Guidelines, Guidelines for adolescent bariatric surgery, Metabolic and bariatric surgery, Morbid obesity, Pediatric, Type 2 diabetes, Weight loss surgery",
author = "Pratt, {Janey S.A.} and Allen Browne and Browne, {Nancy T.} and Matias Bruzoni and Megan Cohen and Ashish Desai and Thomas Inge and Linden, {Bradley C.} and Samer Mattar and Marc Michalsky and David Podkameni and Reichard, {Kirk W.} and Stanford, {Fatima Cody} and Zeller, {Meg H.} and Jeffrey Zitsman",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.soard.2018.03.019",
language = "English (US)",
volume = "14",
pages = "882--901",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

AU - Pratt, Janey S.A.

AU - Browne, Allen

AU - Browne, Nancy T.

AU - Bruzoni, Matias

AU - Cohen, Megan

AU - Desai, Ashish

AU - Inge, Thomas

AU - Linden, Bradley C.

AU - Mattar, Samer

AU - Michalsky, Marc

AU - Podkameni, David

AU - Reichard, Kirk W.

AU - Stanford, Fatima Cody

AU - Zeller, Meg H.

AU - Zitsman, Jeffrey

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009–2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

AB - The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009–2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

KW - Adolescent

KW - Adolescent obesity

KW - Bariatric surgery

KW - Childhood obesity

KW - Guidelines

KW - Guidelines for adolescent bariatric surgery

KW - Metabolic and bariatric surgery

KW - Morbid obesity

KW - Pediatric

KW - Type 2 diabetes

KW - Weight loss surgery

UR - http://www.scopus.com/inward/record.url?scp=85050809540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050809540&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2018.03.019

DO - 10.1016/j.soard.2018.03.019

M3 - Review article

C2 - 30077361

AN - SCOPUS:85050809540

VL - 14

SP - 882

EP - 901

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 7

ER -